Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-08

Clinical Trial Update: Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating long-term use of hCG or hCG plus hMG in males with isolated hypogonadotropic hypogonadism (IHH) and Kallmann syndrome to assess efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hCG (human chorionic gonadotropin)
  • hMG (human menopausal gonadotropin)

Snippet

Sponsor: Tongji Hospital | Conditions: Isolated Hypogonadotropic Hypogonadism, Kallmann Syndrome | Phase 4 | Status: UNKNOWN